Please login to the form below
diabetes
This page shows the latest diabetes news and features for those working in and with pharma, biotech and healthcare.
AZ’s Farxiga has no significant benefit for hospitalised COVID-19 patients
SGLT2 inhibitors – such as Farxiga (dapagliflozin) – can be used to provide organ protection for patients with chronic conditions, such as heart failure and diabetes. ... Initially, Farxiga was approved in 2014 to improve glycemic control in adults
Latest news
-
In sickness and in health
Continuous glucose monitoring has transformed diabetes care in recent years and I’d guess it’s only a matter of time before we. ... Abbott’s work, encouraging diabetes patients to be proactive in managing their glucose levels, is a good example of
-
Gilead and Novo Nordisk boost NASH partnership with new mid-stage study
Semaglutide is already approved to control blood glucose levels in adults with poorly controlled type 2 diabetes.
-
Vertex gains FDA fast track designation for diabetes stem cell therapy
Vertex says VX-880 has potential to restore pancreatic islet cell function, including insulin production, in type 1 diabetes patients. ... The US Food and Drug Administration (FDA) has granted Vertex’s investigational stem cell therapy VX-880 a fast
-
Lilly partners with Biolojic Design to develop diabetes antibody therapies
Diabetes is among Lilly’s core areas of focus, and the company has a number of drugs in the pipeline in this therapy area. ... Among these is tirzepatide, which recently yielded positive results in a head-to-head trial against Novo Nordisk’s
-
Lilly’s tirzepatide shows superiority over Novo’s semaglutide in type 2 diabetes trial
reductions but also significant weight loss to help meet their needs," said Mike Mason, president, Lilly Diabetes. ... Also within Novo’s roster is an oral formulation of semaglutide – marketed under the Rybelsus brand name – that is authorised for
In sickness and in health
Gilead and Novo Nordisk boost NASH partnership with new mid-stage study
Vertex gains FDA fast track designation for diabetes stem cell therapy
Lilly partners with Biolojic Design to develop diabetes antibody therapies
More from news
Approximately 359 fully matching, plus 1,393 partially matching documents found.
Latest Intelligence
-
Alzheimer’s: the search for a cure
They include: smoking, excessive alcohol consumption, diabetes, depression, hypertension, hearing impairment and mid-life obesity, in addition to a lack of social contact and physical exercise.
-
Understand, identify and partner with HCPs to improve patient support
The International Diabetes Federation estimated that in 2019 there were around 463 million people worldwide that have diabetes. ... Diabetes consultant, Partha Kar’s Twitter account was mentioned over 250 times by his HCP peers.
-
A new era for UK-Japanese scientific research relations
Japan’s health system is seeing a corresponding rise in the conditions common to an ageing population, such as cardiac disease, autoimmune diseases, diabetes, osteoporosis and osteoarthritis.
-
The promise of precision medicine
In Qatar, research into genomics and precision medicine is being used to tackle diseases such as obesity, diabetes and cardiovascular disease. ... Diabetes is a particularly complex disease, which involves more than one gene type, and is therefore an
-
Creating strong commercial relationships in a COVID world
There are many potentially life-changing digital innovations on the market. For example, diabetes monitors that are applied to the skin and send patient health metrics remotely to a mobile app.
Alzheimer’s: the search for a cure
Understand, identify and partner with HCPs to improve patient support
A new era for UK-Japanese scientific research relations
The promise of precision medicine
Creating strong commercial relationships in a COVID world
More from intelligence
Approximately 14 fully matching, plus 171 partially matching documents found.
Latest appointments
-
VMLY&Rx taps Nichole Davies for global chief strategy officer role
Her experience spans a number of areas, including oncology and immunology, rare disease, respiratory, women’s health, diabetes, nutrition and hospitals.
-
Sandra Carey takes on global president, expert audiences role at McCann Health
She has also been a practising pharmacist and practitioner for most of her career, working as a clinical pharmacist in a family practice setting, running diabetes and pain management clinics and
-
Evoke KYNE appoints global head of digital
O’Donnell joined Evoke in 2017 with experience in engaging healthcare stakeholders across therapy areas and a particular expertise in psychiatry, neurology and diabetes.
-
New hires at bluebird bio, BioNTech and Provention Bio
In his role as CCO at Provention, Hoitt will be responsible for the development and execution of the company’s global commercial strategy for its type 1 diabetes prevention immunotherapy ... one diabetes (T1D) patients and at-risk individuals and, in
-
New hires at FibroGen, Saniona and Turbine
Eli Lilly and president of Lilly Diabetes and USA.
VMLY&Rx taps Nichole Davies for global chief strategy officer role
Sandra Carey takes on global president, expert audiences role at McCann Health
Evoke KYNE appoints global head of digital
New hires at bluebird bio, BioNTech and Provention Bio
New hires at FibroGen, Saniona and Turbine
More from appointments
Approximately 3 fully matching, plus 66 partially matching documents found.
Latest from PMHub
-
Remote Patient Monitoring
3. It can be especially helpful for patients who are managing a more complex self-care processes such as post-operative care, home dialysis, diabetes or congestive heart failure. Key features
-
Improving Public Health Through Telemedicine
Laurence Girard, CEO of Fruit Street Health, shares his tips for aspiring HealthTech entrepreneurs, his views on the future of telemedicine and digital health, and why he thinks healthcare companies should be funded by healthcare professionals
-
After a busy first quarter, emotive welcomes five new team members
Not only does Dorothy bring with her solid experience in diabetes, CVRM, respiratory and nutrition, she expands emotive’s wide language repertoire to include Mandarin Chinese. .
-
What you can do to help make invisible illnesses more visible?
This can include chronic physical conditions like arthritis and diabetes, or mental illnesses.
-
WHITE PAPER: Why do men die younger?
5. Many of the most common health conditions affecting men including coronary heart disease, diabetes and various cancers are also known to be affected by these habits.
What you can do to help make invisible illnesses more visible?
WHITE PAPER: Why do men die younger?
More from PMHub
Approximately 16 fully matching, plus 121 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- Client Services Director – London or Home Based – Medical Commun...
-
Highly Competitive Salary, Bonus &Benefits
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
- Group Account Director, Patient Engagement & Solutions, Lond...
-
Highly competitive salary
-
Publications Director
-
Competitive Salary
-
Planner
-
Salary TBC
-
Senior Account Manager
-
Salary TBC
- Senior Leadership Role – Medical Communications – North West
-
Highly Competitive Salary, Bonus &Benefits
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
- Medical Writer, Senior Medical Writer, Principal Medical Writer,...
-
Highly Competitive Salary, Bonus &Benefits
- Client Services Director, Patient Engagement & Solutions, Lo...
-
Highly competitive salary
- Novavax announces further delays for regulatory filings of COVID-19 vaccine
- Novartis highlights potential of its radioligand therapy in prostate cancer at ASCO
- Eli Lilly demonstrates Verzenio win in high-risk breast cancer subset at ASCO
- Merck & Co spinoff Organon launches with the aim of 'improving health outcomes for women'
- Positive results for AZ, Merck & Co’s Lynparza in early breast cancer presented at ASCO
- CanSinoBIO considers booster jab for COVID-19 vaccine
- BeiGene’s reveals positive data for Brukinsa in head-to-head Imbruvica trial
- BMS, Acceleron’s Reblozyl shows new improvements for beta thalassemia patients
- Biogen reports new data backing long-term benefit of Spinraza
- G7 expected to donate one billion COVID-19 vaccine doses
- Anna Korving joins Resonant Group as non-executive director
- Resonant Group appoints Stephen Marchant as chief development officer
No results were found
PMHub
Aurora Healthcare Communications
We're a leading healthcare strategic communications agency helping pharmaceutical companies adapt fast to improve the lives of patients and healthcare...
Latest intelligence
- Article:
- The disparity of patient experiences with Crohn’s Disease in Europe and Japan...
- The pursuit of patient diversity in clinical trials
- When all-inclusive isn’t an option, it’s an obligation...
- Overcoming the digital patient recruitment challenges of connecting with patients
- How many irrelevant experiences, ads, emails, direct messages have you rejected this week?...
